nodes	percent_of_prediction	percent_of_DWPC	metapath
Fidaxomicin—ABCB1—Estramustine—prostate cancer	0.147	0.2	CbGbCtD
Fidaxomicin—ABCB1—Cabazitaxel—prostate cancer	0.097	0.132	CbGbCtD
Fidaxomicin—ABCB1—Estrone—prostate cancer	0.0948	0.129	CbGbCtD
Fidaxomicin—ABCB1—Ethinyl Estradiol—prostate cancer	0.0845	0.115	CbGbCtD
Fidaxomicin—ABCB1—Conjugated Estrogens—prostate cancer	0.062	0.0843	CbGbCtD
Fidaxomicin—ABCB1—Mitoxantrone—prostate cancer	0.0564	0.0767	CbGbCtD
Fidaxomicin—ABCB1—Estradiol—prostate cancer	0.0544	0.074	CbGbCtD
Fidaxomicin—ABCB1—Prednisone—prostate cancer	0.0468	0.0637	CbGbCtD
Fidaxomicin—ABCB1—Etoposide—prostate cancer	0.0355	0.0483	CbGbCtD
Fidaxomicin—ABCB1—Docetaxel—prostate cancer	0.0325	0.0442	CbGbCtD
Fidaxomicin—ABCB1—Doxorubicin—prostate cancer	0.0242	0.033	CbGbCtD
Fidaxomicin—ABCB1—Abacavir transmembrane transport—SLC22A3—prostate cancer	0.000668	0.0907	CbGpPWpGaD
Fidaxomicin—ABCB1—Abacavir transmembrane transport—SLC22A1—prostate cancer	0.000545	0.0739	CbGpPWpGaD
Fidaxomicin—Nervous system disorder—Goserelin—prostate cancer	0.000508	0.00197	CcSEcCtD
Fidaxomicin—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000503	0.00195	CcSEcCtD
Fidaxomicin—Malnutrition—Estradiol—prostate cancer	0.000503	0.00195	CcSEcCtD
Fidaxomicin—Skin disorder—Goserelin—prostate cancer	0.000503	0.00195	CcSEcCtD
Fidaxomicin—Skin disorder—Conjugated Estrogens—prostate cancer	0.000498	0.00194	CcSEcCtD
Fidaxomicin—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000498	0.00193	CcSEcCtD
Fidaxomicin—Flatulence—Estradiol—prostate cancer	0.000496	0.00193	CcSEcCtD
Fidaxomicin—Dysgeusia—Estradiol—prostate cancer	0.000493	0.00191	CcSEcCtD
Fidaxomicin—Dizziness—Bicalutamide—prostate cancer	0.000492	0.00191	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Docetaxel—prostate cancer	0.000475	0.00184	CcSEcCtD
Fidaxomicin—Vomiting—Bicalutamide—prostate cancer	0.000473	0.00184	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Etoposide—prostate cancer	0.000472	0.00183	CcSEcCtD
Fidaxomicin—Rash—Bicalutamide—prostate cancer	0.00047	0.00182	CcSEcCtD
Fidaxomicin—Dermatitis—Bicalutamide—prostate cancer	0.000469	0.00182	CcSEcCtD
Fidaxomicin—Headache—Bicalutamide—prostate cancer	0.000467	0.00181	CcSEcCtD
Fidaxomicin—Dysphagia—Docetaxel—prostate cancer	0.000465	0.00181	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Prednisone—prostate cancer	0.000464	0.0018	CcSEcCtD
Fidaxomicin—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000464	0.0018	CcSEcCtD
Fidaxomicin—Dyspnoea—Goserelin—prostate cancer	0.000462	0.00179	CcSEcCtD
Fidaxomicin—Angioedema—Estradiol—prostate cancer	0.00046	0.00179	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Capecitabine—prostate cancer	0.00046	0.00179	CcSEcCtD
Fidaxomicin—Dysgeusia—Mitoxantrone—prostate cancer	0.000459	0.00178	CcSEcCtD
Fidaxomicin—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000457	0.00178	CcSEcCtD
Fidaxomicin—Dyspepsia—Goserelin—prostate cancer	0.000456	0.00177	CcSEcCtD
Fidaxomicin—Abdominal distension—Capecitabine—prostate cancer	0.000453	0.00176	CcSEcCtD
Fidaxomicin—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000452	0.00175	CcSEcCtD
Fidaxomicin—Dysphagia—Capecitabine—prostate cancer	0.00045	0.00175	CcSEcCtD
Fidaxomicin—Decreased appetite—Goserelin—prostate cancer	0.00045	0.00175	CcSEcCtD
Fidaxomicin—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000446	0.00173	CcSEcCtD
Fidaxomicin—Pruritus—Ethinyl Estradiol—prostate cancer	0.000445	0.00173	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000443	0.00172	CcSEcCtD
Fidaxomicin—Constipation—Goserelin—prostate cancer	0.000443	0.00172	CcSEcCtD
Fidaxomicin—Nausea—Bicalutamide—prostate cancer	0.000442	0.00172	CcSEcCtD
Fidaxomicin—Constipation—Conjugated Estrogens—prostate cancer	0.000439	0.0017	CcSEcCtD
Fidaxomicin—Neutropenia—Docetaxel—prostate cancer	0.000435	0.00169	CcSEcCtD
Fidaxomicin—Anaemia—Mitoxantrone—prostate cancer	0.000433	0.00168	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000425	0.00165	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Goserelin—prostate cancer	0.000424	0.00165	CcSEcCtD
Fidaxomicin—Neutropenia—Capecitabine—prostate cancer	0.000421	0.00164	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.00042	0.00163	CcSEcCtD
Fidaxomicin—Dry mouth—Estradiol—prostate cancer	0.000419	0.00163	CcSEcCtD
Fidaxomicin—Dizziness—Ethinyl Estradiol—prostate cancer	0.000416	0.00162	CcSEcCtD
Fidaxomicin—Abdominal pain—Goserelin—prostate cancer	0.00041	0.00159	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Prednisone—prostate cancer	0.000409	0.00159	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Capecitabine—prostate cancer	0.000406	0.00158	CcSEcCtD
Fidaxomicin—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000406	0.00158	CcSEcCtD
Fidaxomicin—Immune system disorder—Etoposide—prostate cancer	0.000405	0.00157	CcSEcCtD
Fidaxomicin—Abdominal distension—Prednisone—prostate cancer	0.000404	0.00157	CcSEcCtD
Fidaxomicin—Nervous system disorder—Estradiol—prostate cancer	0.000403	0.00156	CcSEcCtD
Fidaxomicin—Vomiting—Ethinyl Estradiol—prostate cancer	0.0004	0.00155	CcSEcCtD
Fidaxomicin—Skin disorder—Estradiol—prostate cancer	0.000399	0.00155	CcSEcCtD
Fidaxomicin—Rash—Ethinyl Estradiol—prostate cancer	0.000397	0.00154	CcSEcCtD
Fidaxomicin—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000397	0.00154	CcSEcCtD
Fidaxomicin—Headache—Ethinyl Estradiol—prostate cancer	0.000394	0.00153	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Docetaxel—prostate cancer	0.000392	0.00152	CcSEcCtD
Fidaxomicin—ABCB1—Abacavir transport and metabolism—SLC22A3—prostate cancer	0.000384	0.0521	CbGpPWpGaD
Fidaxomicin—Dysgeusia—Etoposide—prostate cancer	0.000382	0.00148	CcSEcCtD
Fidaxomicin—Hypersensitivity—Goserelin—prostate cancer	0.000382	0.00148	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Capecitabine—prostate cancer	0.00038	0.00148	CcSEcCtD
Fidaxomicin—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000378	0.00147	CcSEcCtD
Fidaxomicin—Neutropenia—Prednisone—prostate cancer	0.000375	0.00146	CcSEcCtD
Fidaxomicin—Nausea—Ethinyl Estradiol—prostate cancer	0.000374	0.00145	CcSEcCtD
Fidaxomicin—Skin disorder—Mitoxantrone—prostate cancer	0.000372	0.00144	CcSEcCtD
Fidaxomicin—Pruritus—Goserelin—prostate cancer	0.000367	0.00142	CcSEcCtD
Fidaxomicin—Dyspnoea—Estradiol—prostate cancer	0.000366	0.00142	CcSEcCtD
Fidaxomicin—Pruritus—Conjugated Estrogens—prostate cancer	0.000363	0.00141	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000363	0.00141	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Prednisone—prostate cancer	0.000362	0.00141	CcSEcCtD
Fidaxomicin—Dyspepsia—Estradiol—prostate cancer	0.000361	0.0014	CcSEcCtD
Fidaxomicin—Anaemia—Etoposide—prostate cancer	0.00036	0.0014	CcSEcCtD
Fidaxomicin—Decreased appetite—Estradiol—prostate cancer	0.000357	0.00139	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Estradiol—prostate cancer	0.000355	0.00138	CcSEcCtD
Fidaxomicin—Constipation—Estradiol—prostate cancer	0.000351	0.00136	CcSEcCtD
Fidaxomicin—Dizziness—Goserelin—prostate cancer	0.000343	0.00133	CcSEcCtD
Fidaxomicin—Dyspnoea—Mitoxantrone—prostate cancer	0.000341	0.00133	CcSEcCtD
Fidaxomicin—Dizziness—Conjugated Estrogens—prostate cancer	0.000339	0.00132	CcSEcCtD
Fidaxomicin—Dyspepsia—Mitoxantrone—prostate cancer	0.000337	0.00131	CcSEcCtD
Fidaxomicin—Immune system disorder—Docetaxel—prostate cancer	0.000336	0.00131	CcSEcCtD
Fidaxomicin—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000336	0.0013	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Estradiol—prostate cancer	0.000336	0.0013	CcSEcCtD
Fidaxomicin—Decreased appetite—Mitoxantrone—prostate cancer	0.000333	0.00129	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.00033	0.00128	CcSEcCtD
Fidaxomicin—Vomiting—Goserelin—prostate cancer	0.000329	0.00128	CcSEcCtD
Fidaxomicin—Constipation—Mitoxantrone—prostate cancer	0.000327	0.00127	CcSEcCtD
Fidaxomicin—Rash—Goserelin—prostate cancer	0.000327	0.00127	CcSEcCtD
Fidaxomicin—Dermatitis—Goserelin—prostate cancer	0.000326	0.00127	CcSEcCtD
Fidaxomicin—Vomiting—Conjugated Estrogens—prostate cancer	0.000326	0.00127	CcSEcCtD
Fidaxomicin—Immune system disorder—Capecitabine—prostate cancer	0.000326	0.00126	CcSEcCtD
Fidaxomicin—Abdominal pain—Estradiol—prostate cancer	0.000325	0.00126	CcSEcCtD
Fidaxomicin—Headache—Goserelin—prostate cancer	0.000325	0.00126	CcSEcCtD
Fidaxomicin—Malnutrition—Docetaxel—prostate cancer	0.000324	0.00126	CcSEcCtD
Fidaxomicin—Rash—Conjugated Estrogens—prostate cancer	0.000324	0.00126	CcSEcCtD
Fidaxomicin—Dermatitis—Conjugated Estrogens—prostate cancer	0.000323	0.00126	CcSEcCtD
Fidaxomicin—Headache—Conjugated Estrogens—prostate cancer	0.000321	0.00125	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Epirubicin—prostate cancer	0.00032	0.00124	CcSEcCtD
Fidaxomicin—Dysgeusia—Docetaxel—prostate cancer	0.000317	0.00123	CcSEcCtD
Fidaxomicin—Abdominal distension—Epirubicin—prostate cancer	0.000316	0.00123	CcSEcCtD
Fidaxomicin—Malnutrition—Capecitabine—prostate cancer	0.000314	0.00122	CcSEcCtD
Fidaxomicin—Dysphagia—Epirubicin—prostate cancer	0.000314	0.00122	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000313	0.00122	CcSEcCtD
Fidaxomicin—ABCB1—Abacavir transport and metabolism—SLC22A1—prostate cancer	0.000313	0.0425	CbGpPWpGaD
Fidaxomicin—Flatulence—Capecitabine—prostate cancer	0.000309	0.0012	CcSEcCtD
Fidaxomicin—Skin disorder—Etoposide—prostate cancer	0.000309	0.0012	CcSEcCtD
Fidaxomicin—Nausea—Goserelin—prostate cancer	0.000308	0.0012	CcSEcCtD
Fidaxomicin—Dysgeusia—Capecitabine—prostate cancer	0.000307	0.00119	CcSEcCtD
Fidaxomicin—Nausea—Conjugated Estrogens—prostate cancer	0.000305	0.00118	CcSEcCtD
Fidaxomicin—Hypersensitivity—Estradiol—prostate cancer	0.000303	0.00118	CcSEcCtD
Fidaxomicin—Abdominal pain—Mitoxantrone—prostate cancer	0.000302	0.00118	CcSEcCtD
Fidaxomicin—Anaemia—Docetaxel—prostate cancer	0.0003	0.00116	CcSEcCtD
Fidaxomicin—Alanine aminotransferase increased—Doxorubicin—prostate cancer	0.000296	0.00115	CcSEcCtD
Fidaxomicin—Neutropenia—Epirubicin—prostate cancer	0.000293	0.00114	CcSEcCtD
Fidaxomicin—Abdominal distension—Doxorubicin—prostate cancer	0.000292	0.00114	CcSEcCtD
Fidaxomicin—Pruritus—Estradiol—prostate cancer	0.000291	0.00113	CcSEcCtD
Fidaxomicin—Dysphagia—Doxorubicin—prostate cancer	0.00029	0.00113	CcSEcCtD
Fidaxomicin—Anaemia—Capecitabine—prostate cancer	0.00029	0.00113	CcSEcCtD
Fidaxomicin—Immune system disorder—Prednisone—prostate cancer	0.00029	0.00113	CcSEcCtD
Fidaxomicin—Dyspnoea—Etoposide—prostate cancer	0.000284	0.0011	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Epirubicin—prostate cancer	0.000283	0.0011	CcSEcCtD
Fidaxomicin—Hypersensitivity—Mitoxantrone—prostate cancer	0.000282	0.0011	CcSEcCtD
Fidaxomicin—Malnutrition—Prednisone—prostate cancer	0.00028	0.00109	CcSEcCtD
Fidaxomicin—Decreased appetite—Etoposide—prostate cancer	0.000277	0.00107	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Etoposide—prostate cancer	0.000275	0.00107	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000274	0.00106	CcSEcCtD
Fidaxomicin—Constipation—Etoposide—prostate cancer	0.000272	0.00106	CcSEcCtD
Fidaxomicin—Dizziness—Estradiol—prostate cancer	0.000272	0.00105	CcSEcCtD
Fidaxomicin—Neutropenia—Doxorubicin—prostate cancer	0.000271	0.00105	CcSEcCtD
Fidaxomicin—Dry mouth—Docetaxel—prostate cancer	0.00027	0.00105	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000265	0.00103	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Epirubicin—prostate cancer	0.000265	0.00103	CcSEcCtD
Fidaxomicin—Hyperglycaemia—Doxorubicin—prostate cancer	0.000262	0.00102	CcSEcCtD
Fidaxomicin—Dry mouth—Capecitabine—prostate cancer	0.000261	0.00101	CcSEcCtD
Fidaxomicin—Vomiting—Estradiol—prostate cancer	0.000261	0.00101	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Etoposide—prostate cancer	0.00026	0.00101	CcSEcCtD
Fidaxomicin—Nervous system disorder—Docetaxel—prostate cancer	0.000259	0.00101	CcSEcCtD
Fidaxomicin—Rash—Estradiol—prostate cancer	0.000259	0.00101	CcSEcCtD
Fidaxomicin—Dermatitis—Estradiol—prostate cancer	0.000259	0.001	CcSEcCtD
Fidaxomicin—Anaemia—Prednisone—prostate cancer	0.000258	0.001	CcSEcCtD
Fidaxomicin—Headache—Estradiol—prostate cancer	0.000257	0.000999	CcSEcCtD
Fidaxomicin—Skin disorder—Docetaxel—prostate cancer	0.000257	0.000998	CcSEcCtD
Fidaxomicin—ABCB1—Codeine and Morphine Metabolism—CYP3A4—prostate cancer	0.000257	0.0349	CbGpPWpGaD
Fidaxomicin—Angioedema—Prednisone—prostate cancer	0.000255	0.000992	CcSEcCtD
Fidaxomicin—Abdominal pain—Etoposide—prostate cancer	0.000252	0.000977	CcSEcCtD
Fidaxomicin—Nervous system disorder—Capecitabine—prostate cancer	0.000251	0.000976	CcSEcCtD
Fidaxomicin—Skin disorder—Capecitabine—prostate cancer	0.000249	0.000966	CcSEcCtD
Fidaxomicin—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000245	0.000951	CcSEcCtD
Fidaxomicin—Nausea—Estradiol—prostate cancer	0.000244	0.000948	CcSEcCtD
Fidaxomicin—Vomiting—Mitoxantrone—prostate cancer	0.000243	0.000945	CcSEcCtD
Fidaxomicin—Rash—Mitoxantrone—prostate cancer	0.000241	0.000937	CcSEcCtD
Fidaxomicin—Dermatitis—Mitoxantrone—prostate cancer	0.000241	0.000936	CcSEcCtD
Fidaxomicin—Headache—Mitoxantrone—prostate cancer	0.00024	0.000931	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000236	0.000918	CcSEcCtD
Fidaxomicin—Dyspnoea—Docetaxel—prostate cancer	0.000236	0.000916	CcSEcCtD
Fidaxomicin—Hypersensitivity—Etoposide—prostate cancer	0.000234	0.000911	CcSEcCtD
Fidaxomicin—Dyspepsia—Docetaxel—prostate cancer	0.000233	0.000905	CcSEcCtD
Fidaxomicin—Decreased appetite—Docetaxel—prostate cancer	0.00023	0.000893	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000228	0.000887	CcSEcCtD
Fidaxomicin—Dyspnoea—Capecitabine—prostate cancer	0.000228	0.000887	CcSEcCtD
Fidaxomicin—Nausea—Mitoxantrone—prostate cancer	0.000227	0.000883	CcSEcCtD
Fidaxomicin—Immune system disorder—Epirubicin—prostate cancer	0.000227	0.000881	CcSEcCtD
Fidaxomicin—Constipation—Docetaxel—prostate cancer	0.000226	0.000879	CcSEcCtD
Fidaxomicin—Dyspepsia—Capecitabine—prostate cancer	0.000225	0.000876	CcSEcCtD
Fidaxomicin—Pruritus—Etoposide—prostate cancer	0.000225	0.000875	CcSEcCtD
Fidaxomicin—Nervous system disorder—Prednisone—prostate cancer	0.000224	0.000869	CcSEcCtD
Fidaxomicin—Decreased appetite—Capecitabine—prostate cancer	0.000223	0.000865	CcSEcCtD
Fidaxomicin—Skin disorder—Prednisone—prostate cancer	0.000222	0.000861	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000221	0.000859	CcSEcCtD
Fidaxomicin—Constipation—Capecitabine—prostate cancer	0.000219	0.000851	CcSEcCtD
Fidaxomicin—Malnutrition—Epirubicin—prostate cancer	0.000219	0.000849	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Docetaxel—prostate cancer	0.000216	0.00084	CcSEcCtD
Fidaxomicin—Flatulence—Epirubicin—prostate cancer	0.000215	0.000837	CcSEcCtD
Fidaxomicin—Dysgeusia—Epirubicin—prostate cancer	0.000214	0.000832	CcSEcCtD
Fidaxomicin—Dizziness—Etoposide—prostate cancer	0.00021	0.000818	CcSEcCtD
Fidaxomicin—Immune system disorder—Doxorubicin—prostate cancer	0.00021	0.000815	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Capecitabine—prostate cancer	0.000209	0.000814	CcSEcCtD
Fidaxomicin—Abdominal pain—Docetaxel—prostate cancer	0.000209	0.000812	CcSEcCtD
Fidaxomicin—Abdominal pain—Capecitabine—prostate cancer	0.000202	0.000786	CcSEcCtD
Fidaxomicin—Vomiting—Etoposide—prostate cancer	0.000202	0.000786	CcSEcCtD
Fidaxomicin—Malnutrition—Doxorubicin—prostate cancer	0.000202	0.000786	CcSEcCtD
Fidaxomicin—Anaemia—Epirubicin—prostate cancer	0.000202	0.000785	CcSEcCtD
Fidaxomicin—Dyspepsia—Prednisone—prostate cancer	0.000201	0.00078	CcSEcCtD
Fidaxomicin—Rash—Etoposide—prostate cancer	0.000201	0.00078	CcSEcCtD
Fidaxomicin—Dermatitis—Etoposide—prostate cancer	0.0002	0.000779	CcSEcCtD
Fidaxomicin—Headache—Etoposide—prostate cancer	0.000199	0.000775	CcSEcCtD
Fidaxomicin—ABCB1—Drug Induction of Bile Acid Pathway—SULT2A1—prostate cancer	0.000199	0.0271	CbGpPWpGaD
Fidaxomicin—Flatulence—Doxorubicin—prostate cancer	0.000199	0.000774	CcSEcCtD
Fidaxomicin—Decreased appetite—Prednisone—prostate cancer	0.000198	0.00077	CcSEcCtD
Fidaxomicin—Dysgeusia—Doxorubicin—prostate cancer	0.000198	0.000769	CcSEcCtD
Fidaxomicin—Constipation—Prednisone—prostate cancer	0.000195	0.000758	CcSEcCtD
Fidaxomicin—Hypersensitivity—Docetaxel—prostate cancer	0.000195	0.000757	CcSEcCtD
Fidaxomicin—Nausea—Etoposide—prostate cancer	0.000189	0.000734	CcSEcCtD
Fidaxomicin—Hypersensitivity—Capecitabine—prostate cancer	0.000189	0.000733	CcSEcCtD
Fidaxomicin—Pruritus—Docetaxel—prostate cancer	0.000187	0.000727	CcSEcCtD
Fidaxomicin—Anaemia—Doxorubicin—prostate cancer	0.000187	0.000726	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Prednisone—prostate cancer	0.000187	0.000725	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000185	0.000718	CcSEcCtD
Fidaxomicin—Dry mouth—Epirubicin—prostate cancer	0.000182	0.000707	CcSEcCtD
Fidaxomicin—Pruritus—Capecitabine—prostate cancer	0.000181	0.000704	CcSEcCtD
Fidaxomicin—Abdominal pain—Prednisone—prostate cancer	0.00018	0.000701	CcSEcCtD
Fidaxomicin—Nervous system disorder—Epirubicin—prostate cancer	0.000175	0.00068	CcSEcCtD
Fidaxomicin—Dizziness—Docetaxel—prostate cancer	0.000175	0.00068	CcSEcCtD
Fidaxomicin—Skin disorder—Epirubicin—prostate cancer	0.000173	0.000673	CcSEcCtD
Fidaxomicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000171	0.000664	CcSEcCtD
Fidaxomicin—Dizziness—Capecitabine—prostate cancer	0.000169	0.000658	CcSEcCtD
Fidaxomicin—Dry mouth—Doxorubicin—prostate cancer	0.000168	0.000654	CcSEcCtD
Fidaxomicin—Vomiting—Docetaxel—prostate cancer	0.000168	0.000653	CcSEcCtD
Fidaxomicin—Hypersensitivity—Prednisone—prostate cancer	0.000168	0.000653	CcSEcCtD
Fidaxomicin—Rash—Docetaxel—prostate cancer	0.000167	0.000648	CcSEcCtD
Fidaxomicin—Dermatitis—Docetaxel—prostate cancer	0.000167	0.000647	CcSEcCtD
Fidaxomicin—Headache—Docetaxel—prostate cancer	0.000166	0.000644	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A5—prostate cancer	0.000164	0.0223	CbGpPWpGaD
Fidaxomicin—Vomiting—Capecitabine—prostate cancer	0.000163	0.000633	CcSEcCtD
Fidaxomicin—Nervous system disorder—Doxorubicin—prostate cancer	0.000162	0.000629	CcSEcCtD
Fidaxomicin—Rash—Capecitabine—prostate cancer	0.000161	0.000627	CcSEcCtD
Fidaxomicin—Pruritus—Prednisone—prostate cancer	0.000161	0.000627	CcSEcCtD
Fidaxomicin—Dermatitis—Capecitabine—prostate cancer	0.000161	0.000627	CcSEcCtD
Fidaxomicin—Headache—Capecitabine—prostate cancer	0.00016	0.000623	CcSEcCtD
Fidaxomicin—Skin disorder—Doxorubicin—prostate cancer	0.00016	0.000623	CcSEcCtD
Fidaxomicin—Dyspnoea—Epirubicin—prostate cancer	0.000159	0.000618	CcSEcCtD
Fidaxomicin—Nausea—Docetaxel—prostate cancer	0.000157	0.00061	CcSEcCtD
Fidaxomicin—Dyspepsia—Epirubicin—prostate cancer	0.000157	0.00061	CcSEcCtD
Fidaxomicin—Decreased appetite—Epirubicin—prostate cancer	0.000155	0.000602	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000154	0.000598	CcSEcCtD
Fidaxomicin—Constipation—Epirubicin—prostate cancer	0.000153	0.000593	CcSEcCtD
Fidaxomicin—Nausea—Capecitabine—prostate cancer	0.000152	0.000591	CcSEcCtD
Fidaxomicin—Dizziness—Prednisone—prostate cancer	0.000151	0.000586	CcSEcCtD
Fidaxomicin—Dyspnoea—Doxorubicin—prostate cancer	0.000147	0.000572	CcSEcCtD
Fidaxomicin—Gastrointestinal pain—Epirubicin—prostate cancer	0.000146	0.000567	CcSEcCtD
Fidaxomicin—Dyspepsia—Doxorubicin—prostate cancer	0.000145	0.000565	CcSEcCtD
Fidaxomicin—Vomiting—Prednisone—prostate cancer	0.000145	0.000563	CcSEcCtD
Fidaxomicin—Rash—Prednisone—prostate cancer	0.000144	0.000559	CcSEcCtD
Fidaxomicin—Dermatitis—Prednisone—prostate cancer	0.000144	0.000558	CcSEcCtD
Fidaxomicin—Decreased appetite—Doxorubicin—prostate cancer	0.000144	0.000557	CcSEcCtD
Fidaxomicin—Headache—Prednisone—prostate cancer	0.000143	0.000555	CcSEcCtD
Fidaxomicin—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000143	0.000554	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—GSTA2—prostate cancer	0.000141	0.0192	CbGpPWpGaD
Fidaxomicin—Constipation—Doxorubicin—prostate cancer	0.000141	0.000548	CcSEcCtD
Fidaxomicin—Abdominal pain—Epirubicin—prostate cancer	0.000141	0.000548	CcSEcCtD
Fidaxomicin—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—prostate cancer	0.000141	0.0191	CbGpPWpGaD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—SULT1A1—prostate cancer	0.00014	0.019	CbGpPWpGaD
Fidaxomicin—Nausea—Prednisone—prostate cancer	0.000136	0.000526	CcSEcCtD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—SERPINB10—prostate cancer	0.000135	0.0184	CbGpPWpGaD
Fidaxomicin—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000135	0.000524	CcSEcCtD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—prostate cancer	0.000133	0.0181	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—BNIP3—prostate cancer	0.000132	0.0179	CbGpPWpGaD
Fidaxomicin—Hypersensitivity—Epirubicin—prostate cancer	0.000131	0.000511	CcSEcCtD
Fidaxomicin—Abdominal pain—Doxorubicin—prostate cancer	0.000131	0.000507	CcSEcCtD
Fidaxomicin—ABCB1—ABC-family proteins mediated transport—ABCG5—prostate cancer	0.000127	0.0172	CbGpPWpGaD
Fidaxomicin—Pruritus—Epirubicin—prostate cancer	0.000126	0.00049	CcSEcCtD
Fidaxomicin—Hypersensitivity—Doxorubicin—prostate cancer	0.000122	0.000472	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—SULT2A1—prostate cancer	0.00012	0.0163	CbGpPWpGaD
Fidaxomicin—Dizziness—Epirubicin—prostate cancer	0.000118	0.000458	CcSEcCtD
Fidaxomicin—Pruritus—Doxorubicin—prostate cancer	0.000117	0.000454	CcSEcCtD
Fidaxomicin—ABCB1—Drug Induction of Bile Acid Pathway—VDR—prostate cancer	0.000114	0.0154	CbGpPWpGaD
Fidaxomicin—Vomiting—Epirubicin—prostate cancer	0.000113	0.000441	CcSEcCtD
Fidaxomicin—Rash—Epirubicin—prostate cancer	0.000112	0.000437	CcSEcCtD
Fidaxomicin—Dermatitis—Epirubicin—prostate cancer	0.000112	0.000437	CcSEcCtD
Fidaxomicin—Headache—Epirubicin—prostate cancer	0.000112	0.000434	CcSEcCtD
Fidaxomicin—Dizziness—Doxorubicin—prostate cancer	0.000109	0.000424	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C19—prostate cancer	0.000107	0.0145	CbGpPWpGaD
Fidaxomicin—Nausea—Epirubicin—prostate cancer	0.000106	0.000412	CcSEcCtD
Fidaxomicin—Vomiting—Doxorubicin—prostate cancer	0.000105	0.000408	CcSEcCtD
Fidaxomicin—Rash—Doxorubicin—prostate cancer	0.000104	0.000404	CcSEcCtD
Fidaxomicin—Dermatitis—Doxorubicin—prostate cancer	0.000104	0.000404	CcSEcCtD
Fidaxomicin—Headache—Doxorubicin—prostate cancer	0.000103	0.000402	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—prostate cancer	0.000103	0.014	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—WRN—prostate cancer	0.000103	0.0139	CbGpPWpGaD
Fidaxomicin—Nausea—Doxorubicin—prostate cancer	9.81e-05	0.000381	CcSEcCtD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—NCOA2—prostate cancer	9.43e-05	0.0128	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—NDRG1—prostate cancer	8.89e-05	0.0121	CbGpPWpGaD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—prostate cancer	8.47e-05	0.0115	CbGpPWpGaD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—prostate cancer	8.37e-05	0.0114	CbGpPWpGaD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—prostate cancer	8.07e-05	0.011	CbGpPWpGaD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—NCOA1—prostate cancer	7.95e-05	0.0108	CbGpPWpGaD
Fidaxomicin—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—prostate cancer	7.56e-05	0.0103	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—VIM—prostate cancer	7.24e-05	0.00982	CbGpPWpGaD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—prostate cancer	6.52e-05	0.00885	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—prostate cancer	6.5e-05	0.00883	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CD82—prostate cancer	5.62e-05	0.00763	CbGpPWpGaD
Fidaxomicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—prostate cancer	5.5e-05	0.00747	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—NCOA2—prostate cancer	5.28e-05	0.00717	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—CXCL12—prostate cancer	4.92e-05	0.00669	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—prostate cancer	4.61e-05	0.00625	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—PRKCZ—prostate cancer	4.58e-05	0.00621	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—prostate cancer	4.47e-05	0.00606	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—NCOA1—prostate cancer	4.45e-05	0.00605	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CXCL12—prostate cancer	4.26e-05	0.00579	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CASP9—prostate cancer	4.02e-05	0.00545	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—prostate cancer	4.01e-05	0.00544	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—TERT—prostate cancer	3.29e-05	0.00447	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—IL10—prostate cancer	3.23e-05	0.00439	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—HSP90AB1—prostate cancer	3.16e-05	0.00429	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—prostate cancer	3.15e-05	0.00427	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—LEP—prostate cancer	3.07e-05	0.00417	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—prostate cancer	3.04e-05	0.00412	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—FASLG—prostate cancer	3e-05	0.00408	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—prostate cancer	2.88e-05	0.00391	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	2.82e-05	0.00383	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—prostate cancer	2.58e-05	0.0035	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—prostate cancer	2.57e-05	0.00349	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—prostate cancer	2.57e-05	0.00348	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—prostate cancer	2.53e-05	0.00343	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—prostate cancer	2.5e-05	0.0034	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—prostate cancer	2.45e-05	0.00332	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—prostate cancer	2.41e-05	0.00327	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—prostate cancer	2.35e-05	0.00319	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—THBS1—prostate cancer	2.33e-05	0.00317	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—prostate cancer	2.3e-05	0.00312	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	2.23e-05	0.00303	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—prostate cancer	2.23e-05	0.00303	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—prostate cancer	2.19e-05	0.00297	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—prostate cancer	2.07e-05	0.0028	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—prostate cancer	2e-05	0.00272	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—prostate cancer	1.98e-05	0.00269	CbGpPWpGaD
Fidaxomicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—prostate cancer	1.94e-05	0.00263	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—prostate cancer	1.93e-05	0.00262	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—prostate cancer	1.88e-05	0.00255	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—prostate cancer	1.82e-05	0.00248	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	1.82e-05	0.00247	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—prostate cancer	1.81e-05	0.00246	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	1.77e-05	0.00241	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	1.77e-05	0.00241	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CXCL8—prostate cancer	1.77e-05	0.0024	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—EP300—prostate cancer	1.75e-05	0.00238	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—prostate cancer	1.7e-05	0.0023	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—CASP3—prostate cancer	1.69e-05	0.0023	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—IL2—prostate cancer	1.69e-05	0.00229	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—prostate cancer	1.66e-05	0.00226	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—prostate cancer	1.66e-05	0.00225	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HAO1—prostate cancer	1.62e-05	0.0022	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—prostate cancer	1.61e-05	0.00219	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—prostate cancer	1.55e-05	0.00211	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—prostate cancer	1.48e-05	0.00201	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	1.44e-05	0.00195	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—VEGFA—prostate cancer	1.44e-05	0.00195	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—ABCG5—prostate cancer	1.33e-05	0.0018	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PSAT1—prostate cancer	1.32e-05	0.0018	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ADI1—prostate cancer	1.32e-05	0.0018	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GRHL1—prostate cancer	1.32e-05	0.0018	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CSAD—prostate cancer	1.32e-05	0.0018	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—TST—prostate cancer	1.32e-05	0.0018	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CBR1—prostate cancer	1.32e-05	0.0018	CbGpPWpGaD
Fidaxomicin—ABCB1—Allograft Rejection—TGFB1—prostate cancer	1.32e-05	0.00179	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	1.26e-05	0.00172	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	1.25e-05	0.0017	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CKMT2—prostate cancer	1.23e-05	0.00167	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—UGT2B15—prostate cancer	1.23e-05	0.00167	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—UGT2B17—prostate cancer	1.23e-05	0.00167	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GRHPR—prostate cancer	1.23e-05	0.00167	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	1.22e-05	0.00166	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	1.18e-05	0.00161	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	1.17e-05	0.00159	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	1.17e-05	0.00159	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTM3—prostate cancer	1.16e-05	0.00157	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—RFK—prostate cancer	1.16e-05	0.00157	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—AOX1—prostate cancer	1.16e-05	0.00157	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PGAM2—prostate cancer	1.16e-05	0.00157	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NAGLU—prostate cancer	1.16e-05	0.00157	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SULT2B1—prostate cancer	1.16e-05	0.00157	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MBTPS1—prostate cancer	1.16e-05	0.00157	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	1.12e-05	0.00151	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	1.1e-05	0.00149	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP3A43—prostate cancer	1.1e-05	0.00149	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—AMACR—prostate cancer	1.1e-05	0.00149	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—DEGS1—prostate cancer	1.1e-05	0.00149	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SRD5A2—prostate cancer	1.1e-05	0.00149	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NAT1—prostate cancer	1.1e-05	0.00149	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	1.08e-05	0.00147	CbGpPWpGaD
Fidaxomicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	1.06e-05	0.00144	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	1.05e-05	0.00142	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HSD17B1—prostate cancer	1.05e-05	0.00142	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	9.97e-06	0.00135	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	9.51e-06	0.00129	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	9.47e-06	0.00129	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	9.33e-06	0.00127	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—B4GALT4—prostate cancer	9.32e-06	0.00127	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HPGD—prostate cancer	9.32e-06	0.00127	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	9.2e-06	0.00125	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	8.99e-06	0.00122	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	8.97e-06	0.00122	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—TNFRSF21—prostate cancer	8.76e-06	0.00119	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	8.56e-06	0.00116	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP7B1—prostate cancer	8.52e-06	0.00116	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MTAP—prostate cancer	8.52e-06	0.00116	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	8.52e-06	0.00116	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	8.35e-06	0.00113	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SULT1E1—prostate cancer	8.31e-06	0.00113	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SRD5A1—prostate cancer	8.31e-06	0.00113	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	8.12e-06	0.0011	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	8.05e-06	0.00109	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HSD17B3—prostate cancer	7.92e-06	0.00108	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ACSL4—prostate cancer	7.92e-06	0.00108	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	7.86e-06	0.00107	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	7.84e-06	0.00106	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PHGDH—prostate cancer	7.6e-06	0.00103	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ARG2—prostate cancer	7.6e-06	0.00103	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—UMPS—prostate cancer	7.6e-06	0.00103	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	7.56e-06	0.00103	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	7.48e-06	0.00102	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—LDHB—prostate cancer	7.45e-06	0.00101	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP3A5—prostate cancer	7.31e-06	0.000993	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	7.27e-06	0.000987	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	7.19e-06	0.000976	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	7.08e-06	0.000962	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PDHA1—prostate cancer	7.06e-06	0.000959	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—TCN2—prostate cancer	7.06e-06	0.000959	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—UCP3—prostate cancer	7.06e-06	0.000959	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTA3—prostate cancer	7.06e-06	0.000959	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HSD3B1—prostate cancer	6.74e-06	0.000915	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLC22A3—prostate cancer	6.74e-06	0.000915	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	6.52e-06	0.000885	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	6.5e-06	0.000883	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—TBXAS1—prostate cancer	6.46e-06	0.000877	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTA4—prostate cancer	6.46e-06	0.000877	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	6.37e-06	0.000865	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTA2—prostate cancer	6.3e-06	0.000855	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SULT1A1—prostate cancer	6.22e-06	0.000844	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ABCG5—prostate cancer	6.22e-06	0.000844	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTA1—prostate cancer	6.07e-06	0.000825	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	6.02e-06	0.000817	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NAT2—prostate cancer	6.01e-06	0.000815	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTO1—prostate cancer	6.01e-06	0.000815	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HSD3B2—prostate cancer	6.01e-06	0.000815	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PLCB2—prostate cancer	5.76e-06	0.000782	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—LRP2—prostate cancer	5.76e-06	0.000782	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP2C18—prostate cancer	5.76e-06	0.000782	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—P4HB—prostate cancer	5.65e-06	0.000767	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	5.53e-06	0.000751	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLC22A1—prostate cancer	5.49e-06	0.000746	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	5.49e-06	0.000745	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SULT2A1—prostate cancer	5.35e-06	0.000727	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	5.35e-06	0.000727	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MED12—prostate cancer	5.27e-06	0.000715	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GNG5—prostate cancer	5.22e-06	0.000709	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOA3—prostate cancer	5.03e-06	0.000683	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—HPGDS—prostate cancer	4.8e-06	0.000652	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP2C19—prostate cancer	4.77e-06	0.000648	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTT1—prostate cancer	4.66e-06	0.000632	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ACHE—prostate cancer	4.66e-06	0.000632	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP2A6—prostate cancer	4.6e-06	0.000625	CbGpPWpGaD
Fidaxomicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	4.52e-06	0.000614	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—AKR1C3—prostate cancer	4.48e-06	0.000608	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PRKACB—prostate cancer	4.45e-06	0.000605	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP17A1—prostate cancer	4.41e-06	0.000598	CbGpPWpGaD
Fidaxomicin—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.36e-06	0.000592	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOA2—prostate cancer	4.2e-06	0.00057	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—SLC5A5—prostate cancer	4.01e-06	0.000544	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP2E1—prostate cancer	3.91e-06	0.000531	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NQO1—prostate cancer	3.87e-06	0.000525	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—TH—prostate cancer	3.81e-06	0.000518	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP3A4—prostate cancer	3.77e-06	0.000512	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP1B1—prostate cancer	3.71e-06	0.000504	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GGT1—prostate cancer	3.59e-06	0.000488	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NCOA1—prostate cancer	3.54e-06	0.000481	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP19A1—prostate cancer	3.49e-06	0.000474	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—RXRA—prostate cancer	3.37e-06	0.000457	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—COMT—prostate cancer	3.24e-06	0.00044	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTP1—prostate cancer	3.23e-06	0.000438	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ITPR1—prostate cancer	3.18e-06	0.000431	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—TYMS—prostate cancer	3e-06	0.000407	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—GSTM1—prostate cancer	2.97e-06	0.000403	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—LPL—prostate cancer	2.91e-06	0.000395	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CYP1A1—prostate cancer	2.81e-06	0.000382	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—ERCC2—prostate cancer	2.79e-06	0.000379	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—MTHFR—prostate cancer	2.62e-06	0.000356	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PPARA—prostate cancer	2.57e-06	0.000349	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CAV1—prostate cancer	2.42e-06	0.000328	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CG—prostate cancer	2.2e-06	0.000299	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—INS—prostate cancer	2.08e-06	0.000283	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—CREBBP—prostate cancer	2.04e-06	0.000277	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CD—prostate cancer	1.94e-06	0.000263	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—NOS3—prostate cancer	1.83e-06	0.000248	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CB—prostate cancer	1.69e-06	0.000229	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PTGS2—prostate cancer	1.67e-06	0.000227	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PTEN—prostate cancer	1.46e-06	0.000198	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—EP300—prostate cancer	1.39e-06	0.000189	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—PIK3CA—prostate cancer	1.03e-06	0.00014	CbGpPWpGaD
Fidaxomicin—ABCB1—Metabolism—AKT1—prostate cancer	8.4e-07	0.000114	CbGpPWpGaD
